-transparent.png){kind=logo}
Acetylcholine, oxotremorine and carbachol, compounds that exhibit muscarinic agonist activity, maximally inhibited basal prolactin secretion from GH3 cells by approx. 50% and intracellular cyclic AMP levels by approx. 20%. Both parameters were inhibited with similar potencies by each agonist. These inhibitory effects were blocked by a muscarinic but not by a nicotinic receptor antagonist. In the presence of VIP or IBMX, which raise intracellular cyclic AMP levels and stimulate hormone release, the degree of muscarinic inhibition was increased, but the potency remained unchanged. Similar changes in the secretory rate of prolactin and growth hormone occurred in these and in cell perifusion experiments. These results suggest that the inhibition of hormone secretion from GH3 cells by muscarinic agonists is mediated by a decrease in intracellular cyclic AMP levels.
R J Wojcikiewicz, and
P R Dobson, and
B L Brown
September 1983,
Molecular pharmacology,
R J Wojcikiewicz, and
P R Dobson, and
B L Brown
January 1981,
The Biochemical journal,
R J Wojcikiewicz, and
P R Dobson, and
B L Brown
September 1988,
Journal of molecular endocrinology,
R J Wojcikiewicz, and
P R Dobson, and
B L Brown
May 1994,
Cellular signalling,
R J Wojcikiewicz, and
P R Dobson, and
B L Brown
September 1982,
FEBS letters,
R J Wojcikiewicz, and
P R Dobson, and
B L Brown
July 1983,
Biochemical and biophysical research communications,
R J Wojcikiewicz, and
P R Dobson, and
B L Brown
January 1995,
Life sciences,
R J Wojcikiewicz, and
P R Dobson, and
B L Brown
April 1994,
Neurological research,
R J Wojcikiewicz, and
P R Dobson, and
B L Brown
April 1978,
Experientia,
R J Wojcikiewicz, and
P R Dobson, and
B L Brown
January 1985,
Neuroendocrinology,
